XGN · Exagen Inc
United States · RS rating 85 · As of 2026-11-03
| Price | 8.34 USD |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 85 / 52 / 91 / 32 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 47 / 69 / 37 |
| Industry group (rank) | Medical-Research Eqp/Svc (46) |
| EPS growth Q/Q | +35.5% |
| Sales growth Q/Q | -3.5% |
| Distance from 52-week high | +29.5% |
| Market cap (USD) | $64.5M |